Showing results (11-20 of 41) with videos related to

Sort By:
Pageof 5
World Journal of Gastroenterology|September 30, 2006
Resistance to activated protein C is a risk factor for fibrostenosis in Crohn's diseaseGottfried Novacek, Wolfgang Miehsler, Julia Palkovits, et al.
Journal of Hepatology|September 4, 2009
Sorafenib attenuates the portal hypertensive syndrome in partial portal vein ligated ratsThomas Reiberger, Bernhard Angermayr, Philipp Schwabl, et al.
IEEE Transactions on Information Technology in Biomedicine : a Publication of the IEEE Engineering in Medicine and Biology Society|April 8, 2010
Computer-aided classification of zoom-endoscopical images using Fourier filtersMichael Häfner, Leonhard Brunauer, Hannes Payer, et al.
The American Journal of Gastroenterology|October 24, 2003
Anti-Saccharomyces cerevisiae antibodies: a stable marker for Crohn's disease during steroid and 5-aminosalicylic acid treatmentAlexander Teml, Verena Kratzer, Barbara Schneider, et al.
The American Journal of Gastroenterology|October 13, 2006
Erythropoietin treatment is associated with more severe thrombocytopenia in patients with chronic hepatitis C undergoing antiviral therapyMonika Homoncik, Wolfgang Sieghart, Elisabeth Formann, et al.
Gastroenterology|July 10, 2002
Rapid suppression of hematopoiesis by standard or pegylated interferon-alphaMarkus Peck-Radosavljevic, Martina Wichlas, Monika Homoncik-Kraml, et al.
Hepatology (Baltimore, Md.)|December 25, 2002
Spontaneous viral clearance in patients with acute hepatitis C can be predicted by repeated measurements of serum viral loadHarald Hofer, Thomas Watkins-Riedel, Oskar Janata, et al.
The American Journal of Gastroenterology|May 7, 2004
Sudden hearing loss in patients with chronic hepatitis C treated with pegylated interferon/ribavirinElisabeth Formann, Rudolf Stauber, Doris-Maria Denk, et al.
Pageof 5